Saregama Q2 FY27 consolidated: Revenue Rs 314.3 cr, PAT Rs 64.2 cr
For Q2 FY27, Saregama India’s consolidated revenue from operations was Rs 314.30 cr and PAT Rs 64.20 cr, up from Rs 230.00 cr and Rs 43.80 cr in Q2 FY26.
Key takeaways
- Rs 314.30 cr revenue from operations in Q2 FY27 vs Rs 230.00 cr in Q2 FY26
- Rs 196.30 cr total expenses in Q2 FY27 vs Rs 145.30 cr in Q2 FY26
- Adjusted EBITDA Rs 118.00 cr in Q2 FY27 vs Rs 84.70 cr in Q2 FY26
- PAT Rs 64.20 cr in Q2 FY27 vs Rs 43.80 cr in Q2 FY26
- Diluted EPS 3.36 in Q2 FY27 vs 2.28 in Q2 FY26
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 314.30 cr | Rs 230.00 cr | +36.7% |
| PAT | Rs 64.20 cr | Rs 43.80 cr | +46.6% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 20.43% of revenue, up 138 bps from 19.04%.
- Revenue rose 36.7% while total expenses rose 35.1%.
• Revenue from operations (Q2 FY27, consolidated): Rs 314.30 cr vs Rs 230.00 cr in Q2 FY26
• Total expenses (Q2 FY27, consolidated): Rs 196.30 cr vs Rs 145.30 cr in Q2 FY26
• Adjusted EBITDA (Q2 FY27, consolidated): Rs 118.00 cr vs Rs 84.70 cr in Q2 FY26
• Content charging cost (Q2 FY27, consolidated): Rs 37.50 cr vs Rs 32.50 cr in Q2 FY26
• Depreciation (Q2 FY27, consolidated): Rs 2.60 cr vs Rs 2.50 cr in Q2 FY26
• Finance cost (Q2 FY27, consolidated): Rs 1.30 cr vs Rs 1.10 cr in Q2 FY26
• Other income (Q2 FY27, consolidated): Rs 5.20 cr vs Rs 11.50 cr in Q2 FY26
• Share of net profit / (loss) of associates (Q2 FY27, consolidated): Rs 4.00 cr vs Rs 0.00 cr in Q2 FY26
• Operational PBT (Q2 FY27, consolidated): Rs 85.80 cr vs Rs 60.10 cr in Q2 FY26
• PBT (Q2 FY27, consolidated): Rs 85.80 cr vs Rs 60.10 cr in Q2 FY26
• Tax (Q2 FY27, consolidated): Rs 21.60 cr vs Rs 16.30 cr in Q2 FY26
• PAT (Q2 FY27, consolidated): Rs 64.20 cr vs Rs 43.80 cr in Q2 FY26
• Diluted EPS (Q2 FY27, consolidated): 3.36 vs 2.28 in Q2 FY26
According to the consolidated statement of financial results summarised in the “Adjusted EBITDA to PAT” section of the investor presentation, Saregama India reported revenue from operations of Rs 314.30 cr for the quarter ended 30th September, 2026 (Q2 FY27), compared with Rs 230.00 cr in the corresponding quarter a year earlier (Q2 FY26). Total expenses rose to Rs 196.30 cr in Q2 FY27 from Rs 145.30 cr in Q2 FY26. This resulted in an Adjusted EBITDA of Rs 118.00 cr in Q2 FY27 versus Rs 84.70 cr in Q2 FY26.
Content charging cost for the quarter was Rs 37.50 cr, up from Rs 32.50 cr in Q2 FY26. Depreciation was Rs 2.60 cr in Q2 FY27, broadly in line with Rs 2.50 cr in the year-ago quarter, while finance cost increased to Rs 1.30 cr from Rs 1.10 cr. Other income declined to Rs 5.20 cr in Q2 FY27 from Rs 11.50 cr in Q2 FY26. Share of net profit / (loss) of associates contributed Rs 4.00 cr in Q2 FY27, compared with nil in Q2 FY26 as per the same table.
Operational profit before tax (Operational PBT) stood at Rs 85.80 cr in Q2 FY27, compared with Rs 60.10 cr in Q2 FY26. With no exceptional item reported for the quarter in this table, PBT was also Rs 85.80 cr in Q2 FY27 versus Rs 60.10 cr a year earlier. Tax expense increased to Rs 21.60 cr from Rs 16.30 cr. Profit after tax (PAT) for Q2 FY27 was Rs 64.20 cr, up from Rs 43.80 cr in Q2 FY26. Diluted EPS for the quarter was 3.36, compared with 2.28 in the corresponding quarter of the previous year, as stated in the same consolidated results summary.
Get Saregama India Ltd's next results the minute they're filed
Results reach the exchange at all hours, most of them after the market closes. Pro puts the filing in your feed as it is published, with our read of the numbers. A free account sees it an hourback for a day.
- We'll start you off following SAREGAMA.
- 14 days free, no card. After that you keep a free account.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.